Apremilast Significantly Improves Genital Psoriasis Symptoms and QoL, reveals study Dr Riya Dave29 Sept 2024 8:00 PM ISTAccording to researchers, apremilast is the only oral phosphodiesterase 4 inhibitor that significantly improves symptoms of genital psoriasis and...
FOREMOST Trial Reveals Apremilast Enhances Disease Control in Early Oligoarticular Psoriatic Arthritis Medha Baranwal24 Sept 2024 9:45 PM ISTUSA: The results of the FOREMOST trial indicate that apremilast is effective for patients with early psoriatic arthritis (PsA) and limited joint...
FDA approves apremilast for severe plaque psoriasis among children Dr. Kamal Kant Kohli28 Aug 2024 1:15 AM ISTThe Food and Drug Administration (FDA) has expanded the approval of apremilast and included treatment of children 6 years of age and older weighing...
Psoriatic Arthritis Treatment with Apremilast effective and may Improve Patient Satisfactio: Study Jacinthlyn Sylvia19 March 2024 7:00 PM ISTA recent real-world study, the APPRAISE study unveiled the effectiveness, tolerability and patient satisfaction with apremilast treatment for...
Deucravacitinib safer and more effective than apremilast for treating moderate to severe scalp psoriasis Dr. Shravani Dali2 Feb 2024 9:45 AM ISTDeucravacitinib is safer and more effective than apremilast for the treatment of moderate to severe scalp psoriasis suggests a new study published in...
Treatment with apremilast safe and effective in patients with genital psoriasis: DISCREET trial Medha Baranwal30 Oct 2023 5:00 AM ISTUSA: A recent phase 3 randomized clinical trial published in the Journal of the American Academy of Dermatology has shed light on the safety and...
Apremilast lowers weight and improves obese patients with psoriasis and psoriatic arthritis Dr. Mahalakshmi Sivashankaran14 May 2023 8:00 PM ISTUSA: A recent study conducted by OM1 Real-World Data Cloud has found that apremilast, a medication used to treat psoriasis and psoriatic arthritis...
Amgen wins patent appeal on psoriasis drug Otzela against Zydus Pharma (USA), Sandoz Ruchika Sharma22 April 2023 1:30 PM ISTThousand Oaks: Amgen has announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District...
Psoriasis drug Apremilast incredibly promising treatment for alcohol use disorder Dr. Kamal Kant Kohli24 Feb 2023 9:45 AM ISTApremilast is an FDA-approved anti-inflammatory medication used to treat psoriasis and psoriatic arthritis. Researchers have found in a new study...
Short course of Apremilast and phototherapy combination not sufficient for psoriasis management Dr.Niharika Harsha B11 Oct 2022 7:30 PM ISTA combination of Phototherapy and apremilast was not effective for the management of Psoriasis Vulgaris as per a recent study that was published in...
Bristol Myers Squibb bags USFDA approval for plaque psoriasis oral treatment Sotyktu Ruchika Sharma12 Sept 2022 1:29 PM ISTPsoriasis is a widely prevalent, chronic, systemic immune-mediated disease.
Expanded use of Amgen psoriasis drug Otezla gets USFDA okay Ruchika Sharma21 Dec 2021 11:00 AM ISTThousand Oaks: Amgen has recently announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast) for the...
